Immunotherapy is used to regulate systemic hyperactivation or hypoactivation to treat
various diseases. Biomaterial‐based immunotherapy systems can improve therapeutic …

Recent research in the vaccine and immunotherapy fields has revealed that biomaterials
have the ability to activate immune pathways, even in the absence of other immune …

Immunotherapy involves the therapeutic alteration of the patient's immune system to identify,
target, and eliminate cancer cells. Dendritic cells, macrophages, myeloid-derived …

Human immune system acts as a pivotal role in the tissue homeostasis and disease
progression. Immunomodulatory biomaterials that can manipulate innate immunity and …

The immune system usually provides a defense against invading pathogenic
microorganisms and any other particulate contaminants. Nonetheless, it has been recently …

Breakthroughs in materials engineering have accelerated the progress of immunotherapy in
preclinical studies. The interplay of chemistry and materials has resulted in improved …

Biomaterials continue to evolve as complex engineered tools for interactively instructing
biological systems, aiding in the understanding and treatment of various disease states …

Polymers, lipids, scaffolds, microneedles, and other biomaterials are rapidly emerging as
technologies to improve the efficacy of vaccines against infectious disease and …

Biomaterials employed to raise therapeutic immune responses have become a complex and
active field. Historically, vaccines have been developed primarily to fight infectious diseases …

Therapies modulating the immune system offer the prospect of treating a wide range of
conditions including infectious diseases, cancer and autoimmunity. Biomaterials can …